MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The use of pallidal deep brain stimulation (GPi-DBS) to treat GNAO1 gene associated hyperkinetic syndromes

    A. Costa, D. Oliveira, M. Malaquias, L. Botelho, C. Silva, E. Cunha, V. Sá Pinto, N. Vila-Chã, I. Carrilho, M. Magalhães, A. Mendes (Porto, Portugal)

    Objective: To describe the clinical features and benefits of GPi-DBS approach in two patients with GNAO1 gene mutations to whom several episodes of choreo-dystonia exacerbations…
  • 2023 International Congress

    Clinical and molecular features of Tunisian patients with Biallelic mutations in Huntington’s Disease

    H. Nehdi, F. Nabli, Z. Saied, S. Ben Sassi, R. Amouri (Tunis, Tunisia)

    Objective: To investigate the clinical and molecular features of HD in homozygous versus heterozygous patients. Background: Huntington’s disease (HD) is a neurodegenerative autosomal dominant disorder…
  • 2023 International Congress

    Studies on mitochondrial dysfunction in the peripheral blood mononuclear cells in an ethnic Indian population of SCA 12 patients

    S. Ansari, J. Rungta, R. Pal, S. Choudhury, R. Banerjee, S. Dey, H. Kumar (Kolkata, India)

    Objective: We chose important mitochondrial genes such as ndufs5, tim22, fis1, dnm1l to understand the alterations in mitochondrial function in the peripheral blood mononuclear cells…
  • 2023 International Congress

    Keeping patients out of care facilities— clozapine rescues Parkinson’s patients with troublesome psychosis unresponsive to quetiapine and pimavanserin.

    J. Iseringhausen, G. Riboldi, K. Astudillo, S. Frucht (New York, USA)

    Objective: We describe a single-center cohort of Parkinson patients in crisis with troublesome psychosis unresponsive to quetiapine and pimavanserin, who were rescued by treatment with…
  • 2023 International Congress

    Action- and emotion-related language abilities in Slovenian-speaking individuals with Parkinson’s disease – a background normative study

    ž. Drakulić Gorše, C. Manouilidou, M. Trošt (Ljubljana, Slovenia)

    Objective: To prepare action-related (AR) and emotion-related (ER) linguistic stimuli in Slovenian language to test language functions in Parkinson's disease (PD) patients. Background: PD patients…
  • 2023 International Congress

    The hypometabolism in anterior cingulate gyrus and thalamus: potential biomarkers of disease progression in progressive supranuclear palsy

    B. Wang, H. Wang (Hangzhou, China)

    Objective: This study aimed to identify differences in FDG uptake and metabolic covariant network (independent component analysis) in progressive supranuclear palsy (PSP) in comparison with…
  • 2023 International Congress

    Case Study: Pitfalls of Commercial Genetic Testing for Huntington’s Disease

    L. Fanty, J. Bravo, S. Corrigan, M. Maczis, L. Kugelmann, A. Wagle Shukla, M. Farrer, N. Mcfarland (Gainesville, USA)

    Objective: We present a family with initial false negative commercial testing for Huntington Disease (HD) and subsequent whole genome sequencing (WGS) that revealed an expanded…
  • 2023 International Congress

    Hearing impairment and non-motor symptoms in Parkinson’s disease: association and impact on quality of life

    E. Garasto, M. Conti, A. Viziano, A. Stefani, M. Pierantozzi, NB. Mercuri, A. Moleti, R. Sisto, T. Schirinzi, R. Cerroni (Rome, Italy)

    Objective: The aim of the study was to investigate the possible correlation between non-motor symptoms (NMS) burden and quality of life (QoL) with hearing impairment…
  • 2023 International Congress

    Ethical considerations in person-centered Parkinson’s disease care: a cross-national comparison of patients’ perspectives

    J. Stuempel, M. van Munster, B. Schmitz-Luhn, T. Mestre, C. Woopen (Bonn, Germany)

    Objective: To identify which ethical requirements are placed by people with Parkinson’s disease (PwPDs) and their care partners on person-centered care. Background: To improve the…
  • 2023 International Congress

    Characterizing the neural response to electrical brain stimulation with spatiotemporal precision in mice.

    J. Hickman, D. Denman (DENVER, USA)

    Objective: An approach to characterize the neural response to electrical brain stimulation with spatiotemporal precision in mice. Background: Electrical brain stimulation is a clinically accessible…
  • « Previous Page
  • 1
  • …
  • 158
  • 159
  • 160
  • 161
  • 162
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley